Form 4: Ingersoll Rand CEO Exercises, Sells Shares
Insider Transaction Report
Ingersoll Rand's Chairman, President, and CEO, Vicente Reynal, exercised stock options and subsequently sold an equal number of shares under a pre-arranged 10b5-1 trading plan.
Summary
- Vicente Reynal, Chairman, President, and CEO of Ingersoll Rand Inc., engaged in transactions on February 11, 2026.
- Exercised 440 stock options to acquire Common Stock at an exercise price of $10.61 per share.
- Immediately sold 440 shares of Common Stock at a price of $100 per share.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on May 22, 2025.
- Following these transactions, Reynal directly beneficially owns 229,668 shares of Common Stock.
- Indirect beneficial ownership includes 147,802 shares in a trust for himself and his spouse, 75,000 shares for his descendants, and 22,500 shares for his spouse and descendants.
- Reynal still directly holds 205,306 fully vested and exercisable stock options.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an executive sale can sometimes be seen negatively, the transaction is routine, pre-planned, and represents the realization of value from compensation, not a significant divestment.
Positives
- The transaction demonstrates the exercise of vested stock options, indicating a realization of value by the CEO.
- The sale price of $100 per share is significantly higher than the exercise price of $10.61, indicating a substantial gain for the CEO on these specific shares.
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which helps mitigate concerns about insider trading.
Negatives
- The sale of shares by a high-ranking executive, even under a 10b5-1 plan, could be perceived by some investors as a lack of confidence, although the number of shares sold is relatively small compared to total holdings.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common occurrences for executives managing their personal portfolios and compensation. These plans are designed to allow insiders to sell shares without being accused of trading on material non-public information.
Stakeholder Impact
- Shareholders: The sale of a small number of shares by the CEO under a 10b5-1 plan is unlikely to have a significant impact on the company's stock price or long-term shareholder value, as it's a routine compensation-related event.
Key Dates
| Date | Description |
|---|---|
| 2025-05-22 | Date Rule 10b5-1 trading plan was adopted by Vicente Reynal. |
| 2026-02-11 | Date of stock option exercise and subsequent sale of common stock. |
| 2026-02-13 | Date the Form 4 was signed by Andrew Schiesl as Attorney-in-Fact for Vicente Reynal. |
| 2026-05-10 | Expiration date of the exercised stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction by the CEO, involving the exercise of vested stock options and the subsequent sale of an equal number of shares under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The number of shares sold is minor relative to the CEO's total holdings, and the transaction was planned well in advance, mitigating any negative interpretations. Therefore, a 'hold' recommendation remains appropriate based solely on this filing.
Keywords
Ingersoll Rand, IR, Vicente Reynal, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, Executive Compensation, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.